As previously suggested-- IMO there is every possibility that your date could be roughly correct and your MOS way low. You conservatively figured from the Oct 6 enrollment completion date.
The average enrollee has been in the study a lot longer than from the study completion date even assuming a very non-linear ramp up of patients and sites in the clinical trial. The study began in early June of 2010.
The possibility where your date is backed up would only enhance the possibility of greater MOS than generally assumed by both you and MOJO. It will be interesting to see where all this falls out.
The entire study seems to have been enrolled over a 17 month period. In our in house calculation, we conservatively assume 25% enrollment in the first 8.5 months and 75% of the enrollment in the last 8.5 mos. Our blended average for current MOS equals 16.25 mos and counting. Even if we are considerably high in estimate we believe your estimates are considerably low.
Please let me know if you disagree with starting enrollment date or ramp up estimates of weighted clinical patients and we would recalculate.